Literature DB >> 12378630

Investigation of HGV and TTV infection in sera and saliva from non-hepatitis patients with oral diseases.

Jie Yan1, Li-Li Chen, Yong-Liang Lou, Xiao-Zhi Zhong.   

Abstract

AIM: To determine the frequencies of HGV and TTV infections in serum and saliva samples of non-hepatitis patients with oral diseases in Hangzhou area, and to understand the correlation between detected results of HGV RNA and/or TTV DNA in sera and in saliva from the same patients.
METHODS: RT-nested PCR for HGV RNA detection and semi-nested PCR for TTV DNA detection were performed in the serum and saliva samples from 226 non-hepatitis patients with oral diseases, and nucleotide sequence analysis.
RESULTS: Twenty-seven (11.9 %) and 21 (9.3 %) of the 226 serum samples were only positive for HGV RNA and TTV DNA, respectively. 10 (4.4 %) and 9 (3.9 %) of the 226 saliva samples were only positive for HGV RNA and TTV DNA, respectively. And 7 (3.1 %) of the serum samples and 2 (0.9 %) of the saliva samples showed the positive amplification results for both HGV RNA and TTV DNA. 12 saliva samples from the 34 patients (35.3 %) with HGV or HGV/TTV viremia and 11 saliva samples from the 28 patients (39.3 %) with TTV or HGV/TTV viremia were HGV RNA detectable, respectively, including two patients positive for both HGV RNA and TTV DNA in serum and saliva samples. No saliva samples from the 226 patients were found to be HGV RNA or TTV DNA detectable while their serum samples were negative for HGV or TTV. Homologies of the nucleotide sequences of HGV and TTV amplification products from the serum and saliva samples of the two patients compared with the reported sequences were 88.65-91.49 % and 65.32-66.67 %, respectively. In comparison with the nucleotide sequences of amplification products between serum and from saliva sample from any one of the two patients, the homologies were 98.58 % and 99.29 % for HGV, and were 98.65 % and 98.20 % for TTV, respectively.
CONCLUSION: Relatively high carrying rates of HGV and/or TTV in the sera of non-hepatitis patients with oral diseases in Hangzhou area are demonstrated. Parts of the carriers are HGV and/or TTV positive in their saliva. The results of this study indicate that dentists may be one of the populations with high risk for HGV and/or TTV infection, and by way of saliva HGV and TTV may be transmitted among individuals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12378630      PMCID: PMC4656575          DOI: 10.3748/wjg.v8.i5.857

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  62 in total

1.  High frequencies of HGV and TTV infections in blood donors in Hangzhou.

Authors:  J Yan; L L Chen; Y H Luo; Y F Mao; M He
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

2.  The serological prevalence and risk factor analysis of hepatitis G virus infection in Hubei Province of China.

Authors:  De-Ying Tian; Dao-Feng Yang; Ning-Shao Xia; Zheng-Gang Zhang; Hong-Bo Lei; Yuan-Cheng Huang
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

3.  Detection of HBV DNA and its existence status in liver tissues and peripheral blood lymphocytes from chronic hepatitis B patients.

Authors:  Ren-Xian Tang; Feng-Guang Gao; Ling-Yu Zeng; Ying-Wei Wang; Yu-Long Wang
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

4.  A cross-sectional study on HGV infection in a rural population.

Authors:  Bin-Hua Ling; Hui Zhuang; Yi-Hui Cui; Wen-Feng An; Zhi-Jie Li; Shu-Ping Wang; Wan-Fu Zhu
Journal:  World J Gastroenterol       Date:  1998-12       Impact factor: 5.742

5.  GB virus C prevalence in blood donors and high risk groups for parenterally transmitted agents from Gauteng, South Africa.

Authors:  A Casteling; E Song; J Sim; D Blaauw; A Heyns; R Schweizer; L Margolius; E Kuun; S Field; B Schoub; E Vardas
Journal:  J Med Virol       Date:  1998-06       Impact factor: 2.327

6.  The significance of hepatitis G virus infection in patients with non-A to C hepatic diseases.

Authors:  T Tanaka; G Hess; S Tanaka; M Kohara
Journal:  Hepatogastroenterology       Date:  1999 May-Jun

7.  Detection of hepatitis G virus (GB virus C) RNA in human saliva.

Authors:  M Chen; A Sönnerborg; B Johansson; M Sällberg
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

8.  Prevalence and clinical and histological manifestation of hepatitis G/GBV-C infections in patients with elevated aminotransferases of unknown etiology.

Authors:  C Sarrazin; G Herrmann; W K Roth; J H Lee; S Marx; S Zeuzem
Journal:  J Hepatol       Date:  1997-08       Impact factor: 25.083

9.  Clinicopathological study on TTV infection in hepatitis of unknown etiology.

Authors:  Zhong-Jie Hu; Zhen-Wei Lang; Yu-Sen Zhou; Hui-Ping Yan; De-Zhuang Huang; Wan-Rong Chen; Zhao-Xia Luo
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

10.  Detection of a novel DNA virus (TTV) in blood donors and blood products.

Authors:  P Simmonds; F Davidson; C Lycett; L E Prescott; D M MacDonald; J Ellender; P L Yap; C A Ludlam; G H Haydon; J Gillon; L M Jarvis
Journal:  Lancet       Date:  1998-07-18       Impact factor: 79.321

View more
  2 in total

1.  Pathogenicity of GB virus C on virus hepatitis and hemodialysis patients.

Authors:  Wan-Fu Zhu; Li-Min Yin; Peng Li; Jian Huang; Hui Zhuang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

2.  Salivary Genomics, Transcriptomics and Proteomics: The Emerging Concept of the Oral Ecosystem and their Use in the Early Diagnosis of Cancer and other Diseases.

Authors:  T K Fábián; P Fejérdy; P Csermely
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.